What are the half-lives of ranibizumab and aflibercept (VEGF Trap-eye) in human eyes? Calculations with a mathematical model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

What are the half-lives of ranibizumab and aflibercept (VEGF Trap-eye) in human eyes? Calculations with a mathematical model

Published:2011-06-09 Issue:1 Volume:1 Page:
ISSN:2039-4756
Container-title:Eye Reports
language:
Short-container-title:Eye Rep

Author:

Stewart Michael W.

Publisher

PAGEPress Publications

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Summary of the Therapeutic Options for Patients with Dry and Neovascular AMD;Journal of Clinical Medicine;2024-07-19

2. Pre-operative versus post-operative intravitreal aflibercept injection for management of DME in patients undergoing cataract surgery;Graefe's Archive for Clinical and Experimental Ophthalmology;2023-06-17

3. Antiangiogenic AAV2 gene therapy with a truncated form of soluble VEGFR-2 reduces the growth of choroidal neovascularization in mice after intravitreal injection;Experimental Eye Research;2022-11

4. Anti-vascular endothelial growth factor therapy in retinopathy of prematurity;Saudi Journal of Ophthalmology;2022-07

5. The efficacy of different anti-vascular endothelial growth factor agents and prognostic biomarkers in monitoring of the treatment for myopic choroidal neovascularization;International Ophthalmology;2022-03-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP